Position in NTRA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$25,519,014
+$8,505,065 QoQ
Shares Held
94,010
+10.5% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#132
of 846 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SEB Asset Management AB holds $303,338,840 across 12 Diagnostics & Research names. NTRA ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
200,561 | $100,553,262 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
215,189 | $41,578,818 | |
| 3 | DGX |
Quest Diagnostics Inc
|
182,906 | $38,766,926 | |
| 4 | DHR |
Danaher Corp /De/
|
164,432 | $31,321,007 | |
| 5 | NTRA |
Natera, Inc.
This page
|
94,010 | $25,519,014 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
34,205 | $18,006,880 | |
| 7 | RDNT |
RadNet, Inc.
|
180,298 | $11,118,977 | |
| 8 | ILMN |
Illumina, Inc.
|
48,808 | $8,581,910 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,519,014 | 94,010 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $17,013,949 | 85,074 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||